| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/35262899_HAS_TOPIC_C0008976> <https://research.tib.eu/covid-19/entity/35262899_HAS_TOPIC_C0016441> <https://research.tib.eu/covid-19/entity/35262899_HAS_TOPIC_C0026338> <https://research.tib.eu/covid-19/entity/35262899_HAS_TOPIC_C0026346> <https://research.tib.eu/covid-19/entity/35262899_HAS_TOPIC_C0026348> <https://research.tib.eu/covid-19/entity/35262899_HAS_TOPIC_C0041434> <https://research.tib.eu/covid-19/entity/35262899_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/35262899_HAS_TOPIC_C0524785> <https://research.tib.eu/covid-19/entity/35262899_HAS_TOPIC_C0679809> <https://research.tib.eu/covid-19/entity/35262899_HAS_TOPIC_C0687742> <https://research.tib.eu/covid-19/entity/35262899_HAS_TOPIC_C0814767> <https://research.tib.eu/covid-19/entity/35262899_HAS_TOPIC_C1615608> <https://research.tib.eu/covid-19/entity/35262899_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/35262899_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'F. Hoffmann-La Roche AG, 4070, Basel, Switzerland.\', \'F. Hoffmann-La Roche AG, 4070, Basel, Switzerland. timothe.menard@roche.com.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Koneswarakantha_Bj%C3%B6rn> <https://research.tib.eu/covid-19/entity/M%C3%A9nard_Timoth%C3%A9>
?:doi	10.1007/s43441-022-00388-y
?:doi	<https://research.tib.eu/covid-19/entity/10.1007/s43441-022-00388-y>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Research_Support%2C_Non-U.S._Gov%27t>
?:journal	Therapeutic innovation & regulatory science
is ?:pmid of	<https://research.tib.eu/covid-19/entity/35262899>
?:pmid	<https://research.tib.eu/covid-19/entity/35262899>
?:pmid	35262899
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	-1.0
?:rankingScore_hIndex	-1
?:title	Statistical Modeling for Quality Risk Assessment of Clinical Trials: Follow-Up at the Era of Remote Auditing.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2022

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/35262899>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/35262899>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all